Effect of a combination of pertuzumab, trastuzumab, and weekly paclitaxel on pCR rates and side-effect profile as a neoadjuvant treatment regimen for HER2-positive breast cancer von Gupta, Niraj K., Giblin, Erica, Leagre, Christopher A., Govert, Kristen, Givens, Stanley, Chichester, Tiffany, Locker, Matthew, Bhayani, Parin, Burnett, Riesa, Spivey, Tara, Cohen, Stephanie, Paul, Robert

Volltext